-- 週一下午，醫療保健類股下跌，紐約證券交易所醫療保健指數下跌0.4%，道富醫療保健精選行業SPDR ETF（XLV）下跌0.5%。 iShares生物技術ETF（IBB）下跌0.3%。 公司新聞方面，禮來公司（LLY）已同意以最高70億美元收購臨床階段生物技術公司Kelonia Therapeutics，這家製藥巨頭希望藉此加強其癌症治療產品組合。禮來股價下跌0.1%。
Related Articles
Asia
Seatrium Concludes the Divestment of Tugboat Fleet
Seatrium (SGX:5E2) completed the divestment of a fleet of 17 tugboats, according to a Monday filing with the Singapore Exchange.The divestment is expected to deliver over SG$50 million in annualized cost savings.Shares of the specialized engineering solutions company were down over 2% in Monday trading.
$SGX:5E2
Asia
China Nuclear Engineering's Attributable Profit Slides 36% in 2025
China Nuclear Engineering's (SHA:601611) attributable profit fell 36% to 1.32 billion yuan in 2025 from 2.06 billion yuan in 2024, according to a Saturday filing with the Shanghai bourse.Earnings per share at the nuclear power company decreased 37% to 0.36 yuan from 0.57 yuan in the previous year.Operating revenue declined 10% year over year to 101.9 billion yuan from 113.5 billion yuan.Shares decreased 2% during the midday break on Monday.
$SHA:601611
Asia
Junzheng Energy & Chemical's Attributable Profit Rises 18% in 2025; Shares Rise 4%
Inner Mongolia Junzheng Energy & Chemical's (SHA:601216) attributable profit rose 18% to 3.32 billion yuan in 2025 from 2.80 billion yuan in 2024, according to a Saturday filing with the Shanghai bourse.Earnings per share at the chemical manufacturer increased to 0.3932 yuan from 0.3323 yuan in the previous year.Operating revenue stayed flat at 25.2 billion yuan.Shares increased 4% during the midday break on Monday.
$SHA:601216